SSKN Logo

STRATA Skin Sciences, Inc. (SSKN) 

NASDAQ
Market Cap
$13.14M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
89 of 776
Rank in Industry
9 of 100

Largest Insider Buys in Sector

SSKN Stock Price History Chart

SSKN Stock Performance

About STRATA Skin Sciences, Inc.

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other …

Insider Activity of STRATA Skin Sciences, Inc.

Over the last 12 months, insiders at STRATA Skin Sciences, Inc. have bought $1.52M and sold $320 worth of STRATA Skin Sciences, Inc. stock.

On average, over the past 5 years, insiders at STRATA Skin Sciences, Inc. have bought $565,361 and sold $320 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Accelmed Partners, L.P. (10 percent owner) — $723,999. Geiger Uri () — $723,999. Rafaeli Dolev (Chief Executive Officer) — $59,974.

The last purchase of 230,573 shares for transaction amount of $723,999 was made by Geiger Uri () on 2024‑07‑15.

List of Insider Buy and Sell Transactions, STRATA Skin Sciences, Inc.

2024-07-15Purchase
230,573
6.5974%
$3.14$723,9990.00%
2024-07-15Purchase10 percent owner
230,573
6.5974%
$3.14$723,9990.00%
2024-07-15PurchaseChief Executive Officer
19,100
0.5465%
$3.14$59,9740.00%
2023-12-01PurchaseCOO
20,000
0.0586%
$0.45$8,956-5.01%
2023-11-16Saledirector
1,000
0.0021%
$0.32$320-2.87%
2023-08-16Purchase10 percent owner
1.85M
5.0569%
$0.55$1.02M-11.47%
2023-08-10PurchaseChief Executive Officer
42,000
0.1268%
$0.67$28,308-18.75%
2023-08-10PurchaseChief Financial Officer
15,151
0.0455%
$0.67$10,153-18.75%
2022-06-15Purchase
1,050
0.0031%
$1.04$1,092-2.97%
2022-05-12PurchaseChief Financial Officer
23,131
0.0691%
$1.12$25,907-7.96%
2022-03-25Purchase
16,950
0.0523%
$1.73$29,385-38.40%
2022-03-24PurchaseChief Executive Officer
33,300
0.0962%
$1.57$52,398-36.37%
2022-03-24Purchase
14,783
0.043%
$1.58$23,387-36.37%
2021-09-08Purchasedirector
44,808
0.1677%
$1.47$65,951-5.96%
2021-09-07Purchasedirector
26,612
0.0995%
$1.42$37,726-2.41%
2019-11-21Purchasedirector
5,000
0.0158%
$2.50$12,500-44.13%
2018-06-14PurchaseCFO
10,000
0.0431%
$1.96$19,618+42.05%
2018-06-14Purchasedirector
5,000
0.0214%
$1.95$9,750+42.05%
2018-06-08Purchasedirector
30,000
0.1314%
$2.12$63,500+34.06%
2018-06-05Purchasedirector
20,000
0.0855%
$2.01$40,122+37.81%

Insider Historical Profitability

21.59%
Geiger Uri
1441835
34.5668%
$3.1510
Accelmed Partners, L.P.10 percent owner
1441835
34.5668%
$3.1510
Rubinstein Samueldirector
177602
4.2579%
$3.1511
Rafaeli DolevChief Executive Officer
143156
3.432%
$3.1510
Gov ShmuelCOO
20000
0.4795%
$3.1510

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
22Nw Fund Lp$2.03B153.165.37M0%+$095.37
Nantahala Capital Management Llc$1.17B88.133.09M-1.23%-$14.48M54.38
Renaissance Technologies$402,000.0030.311.06M-0.43%-$1,739.85<0.01
The Vanguard Group$324.4M24.48858,2020%+$00.01
One Seven (We Are One Seven, LLC)$64.8M4.89171,420+140.02%+$37.8M3.47
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.